These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation? Lip GY J R Coll Physicians Edinb; 2012; 42 Suppl 18():35-44. PubMed ID: 22518392 [TBL] [Abstract][Full Text] [Related]
3. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184 [TBL] [Abstract][Full Text] [Related]
5. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting. Agarwal S; Bennett D; Smith DJ Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933 [TBL] [Abstract][Full Text] [Related]
6. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M; Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865 [TBL] [Abstract][Full Text] [Related]
9. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan. Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379 [TBL] [Abstract][Full Text] [Related]
10. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative]. Själander A; Wallentin L; Rosenqvist M; Svensson P Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862 [No Abstract] [Full Text] [Related]
11. [Atrial fibrillation and thromboembolic events prevention. State of the art]. Matteoli S; Trappolini M; Chillotti FM Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381 [TBL] [Abstract][Full Text] [Related]
12. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1. Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521 [TBL] [Abstract][Full Text] [Related]
13. Antithrombotic treatment in atrial fibrillation. Lip GY; Boos CJ Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982 [TBL] [Abstract][Full Text] [Related]
14. Incidental atrial fibrillation and its management. Saliba W Postgrad Med; 2011 Mar; 123(2):27-35. PubMed ID: 21474890 [TBL] [Abstract][Full Text] [Related]
15. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
16. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies. Strong SH; Halperin JL Geriatrics; 2007 Mar; 62(3):22-7. PubMed ID: 17346095 [TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study. ROCKET AF Study Investigators Am Heart J; 2010 Mar; 159(3):340-347.e1. PubMed ID: 20211293 [TBL] [Abstract][Full Text] [Related]
18. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation. Hylek EM Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532 [No Abstract] [Full Text] [Related]
19. Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice. Bajorek B; Magin PJ; Hilmer S; Krass I J Clin Pharm Ther; 2016 Aug; 41(4):432-40. PubMed ID: 27338004 [TBL] [Abstract][Full Text] [Related]
20. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation. Mant JW Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531 [No Abstract] [Full Text] [Related] [Next] [New Search]